Directorio

We are doing this study to find out if an experimental drug called mosunetuzumab (the study drug) is a safe and effective option for patients with follicular lymphoma.

What happens in this study? - People will answer questions by phone, online, or in person - They'll give blood samples regularly - Some will do extra tests to check blood sugar, body signals, and blood vessel health - The study will last two years - Doctors will also look at medical records over time to learn more

We are doing this study to compare 3 different kinds of brain training to find out which is most effective in improving cognitive outcomes and everyday functioning for people with mild cognitive impairment or memory loss. Participants who take part in this study will do the brain training at home.

This study wants to help U.S. Veterans with brain injuries and stress problems. People who join will talk with researchers and answer questions three times over six months. They will use a phone app for brain training for 12 weeks. A family member or friend will join three video calls to help during the study.

We are doing this study to find out if neratinib combined with palbociclib is better than neratinib alone when it comes to treating HER2-positive tumors.

We are doing this study to learn more about how right hemisphere brain damage (RHD) from a stroke can affect people's ability to communicate. We want to improve treatments to help stroke survivors regain their ability to communicate.

We are doing this study to identify new signs and symptoms of inflammatory bowel disease (IBD) in children and young adults. We want to improve at predicting the future course of IBD so that we can treat it better and faster. We also hope this study will help us learn how IBD develops so that we can make new treatments for IBD.